Sharp Life Science (EU) Limited Revenue and Competitors
Estimated Revenue & Valuation
- Sharp Life Science (EU) Limited's estimated annual revenue is currently $1M per year.
- Sharp Life Science (EU) Limited's estimated revenue per employee is $251,000
Employee Data
- Sharp Life Science (EU) Limited has 4 Employees.
- Sharp Life Science (EU) Limited grew their employee count by 0% last year.
Sharp Life Science (EU) Limited Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $86.6M | 345 | 2% | N/A | N/A |
#2 | $369.5M | 920 | -23% | $974.7M | N/A |
#3 | $1M | 4 | 0% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $19.8M | 79 | -2% | N/A | N/A |
#7 | $51.7M | 206 | 7% | N/A | N/A |
#8 | $40.9M | 163 | 10% | N/A | N/A |
#9 | $85.1M | 339 | 9% | N/A | N/A |
#10 | $40.4M | 161 | 8% | N/A | N/A |
What Is Sharp Life Science (EU) Limited?
Sharp Life Science (EU) Ltd is a medical device company whose aQdrop technology platform delivers complete control over tiny droplets of fluid. Standard laboratory analysis processes are enabled by smart droplet manipulations ensuring high quality, reliable and reproducible automation of assays for Life Science and Healthcare applications.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Sharp Life Science (EU) Limited News
The bill encourages the U.S., the EU and other European countries to work together on ... on foreign drugs and pharmaceutical ingredients into sharp relief,...
But the science suggesting that industrial societies have thrown ... ENVIRONMENTAL DESTRUCTION HAS been a fact of life since at least the...
European leaders announced the decision on Friday after a historic ... The International Committee of the Red Cross has come under sharp...
... and Europe's largest car auction operator, BCA Marketplace (BCA), which I am ... offer complementary investment capabilities with limited overlap, evenly ... temperature monitoring for healthcare and life sciences within the UK, and .... what was a
Tiziana Life Sciences plc (TLSA), a biotechnology company ... As per the study protocol, data collection was limited to 6-months. ... Sorafenib® (Bayer) was approved, based on the clinical data from the pivotal Phase 3 (SHARP) clinical .... States and EU as first line-treatment for advanced HCC patients.
Other Companies in Oxford
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 4 | -20% | N/A |
#2 | $0.5M | 4 | -20% | N/A |
#3 | $0.3M | 4 | 0% | N/A |
#4 | $0.2M | 4 | -33% | N/A |
#5 | $0.5M | 4 | -20% | N/A |